Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Withdrawal of registration statement filed under the Securities Act

RW
Other
0001103021-00-000004.pdf 0001103021-00-000004.rtf View HTML

Optional form for the registration of securities to be sold to the public by small business issuers

SB-2
Registration Statements
0001103021-00-000003.pdf 0001103021-00-000003.rtf 0001103021-00-000003.xls View HTML

Amendment to a previously filed 10SB12G

10SB12G/A
Registration Statements
0001103021-00-000002.pdf 0001103021-00-000002.rtf 0001103021-00-000002.xls View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
TSAI AARON 0001082990-00-000061.pdf 0001082990-00-000061.rtf 0001082990-00-000061.xls View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
Other
TSAI AARON 0001082990-00-000025.pdf 0001082990-00-000025.rtf View HTML

Registration for small business issuers pursuant to section 12(g) of Securities Exchange Act

10SB12G
Registration Statements
0001103021-00-000001.pdf 0001103021-00-000001.rtf 0001103021-00-000001.xls View HTML

Data provided by Kaleidoscope.

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon